Services Database Take Home Naloxone

This THN service relates to the supply to people aged 18 years or over for someone who is using or has previously used opioids (illicit/prescribed) and is at potential risk of overdose, their carers, family members or friends liable to be on hand in case of overdose. It covers the use of:
• Prenoxad® - intramuscular (given by injection into the upper arm/leg muscle) naloxone solution for injection. The concentration is 1mg/1ml. Each pack contains 1x2ml i.e. 2mg in each prefilled syringe and 2 x 23G 1.25” needles.
• Nyxoid® - intranasal spray (sprayed into the nose) nasal spray. Each single dose container contains
1.8mg. Each pack contains two nasal sprays.

• This Service may only be undertaken by competent Pharmacy staff and under the supervision of the Responsible Pharmacist registered with the GPhC.
• Pharmacy staff must be trained and assessed using Appendix A ‘Pharmacy Staff Naloxone
  Competency Assessment and Supply Form’, which must then be filed locally and kept readily
  accessible for audit and inspection purposes. This form may also be used to record supplies given to Pharmacy Staff for their personal issue.
• The assessor must ensure that the trainee has met all of the listed criteria and fully understands all requirements before signing to confirm their competence.
• Training may be provided either individually or in groups.
• Training may be provided remotely, and information conveyed e.g. in writing/via remote consultation via any suitable medium, so long as the trainer has been provided with assurances that the person can demonstrate the required competencies.
• Only placebo packs may be used for the purposes of training. They can be sourced direct from the manufacturer.
• Additional resources for training include:
  o Prenoxad®: http://www.prenoxadinjection.com/downloads/clients_guide.pdf
  o Nyxoid®: https://www.medicines.org.uk/emc/product/9292/video
  https://www.medicines.org.uk/emc/product/9292/rmms
• It is the responsibility of the Pharmacy to ensure that the staff undertaking the Service have received appropriate training, including completion of relevant competencies/accreditation and relevant health and safety training.
• Mandatory training in the delivery of the THN service is provided by Humankind which may be delivered virtually, and the Pharmacy must retain a training record for each member of staff. Additionally, all Pharmacy staff should be encouraged to complete the free online training courses from SMMGP at https://www.ap-elearning.org.uk/ (individual registration required).
• The Responsible Pharmacist must have completed Safeguarding training to Level 2 and be DBSchecked in line with current guidance, which must be rechecked/updated in response to any legislative/best practice guidance changes. The Responsible Pharmacist must ensure the suitability of any Pharmacy staff who are one-to-one with a vulnerable service user.
• Where locums or part time staff predominantly operate a Pharmacy, the Superintendent Pharmacist or delegated deputy must nominate a lead person to act as a contact. This must be communicated to Humankind promptly.
• Humankind will seek to provide at least one training event per year (face-to-face or online) which will usually be available for access by the wider Pharmacy Team (including locum staff), to support broader development of competency and confidence in the management of substance misuse. The Pharmacy must be represented by at least one member of staff at a minimum of one event per year.
• The Responsible Pharmacist on duty at any time will retain professional responsibility and the Pharmacy shall retain liability for the Service.